About Dr. Govind Eriat

• Dr. Govind Eriat is a highly respected Hematologist and Bone Marrow Transplant (BMT) physician with more than 13 years of experience in treating complex hematological disorders and managing advanced transplant cases.
• With extensive hands-on experience in more than 400 bone marrow transplants, Dr. Eriat is adept in both autologous and allogeneic transplants, including haploidentical and mismatched donor transplants, which are among the most challenging procedures in hematology.
• His expertise also extends to the management of acute and chronic leukemias, lymphomas, aplastic anemia, myelodysplastic syndromes, multiple myeloma, and rare cytopenic disorders.
• One of his areas of special interest includes bloodless medicine and surgery, offering transfusion-free therapy options for patients such as Jehovah’s Witnesses, ensuring safe and ethical care while respecting patient beliefs.
• Dr. Eriat is also deeply involved in the development of stem cell therapies for neuroregeneration and immunotherapy-based treatments for refractory autoimmune disorders like Multiple Sclerosis and Systemic Lupus Erythematosus (SLE).
• He holds an MBBS from Yenepoya Medical College, Bangalore, followed by DNB in Internal Medicine, and is a Fellow of the Royal College of Physicians of Glasgow (FRCP), reflecting his academic excellence and adherence to global standards of medical practice.
• An alumnus of the National Board of Examinations, Dr. Eriat further honed his expertise through the prestigious Leukemia & Bone Marrow Transplant Fellowship at the University of British Columbia, Vancouver, Canada.
• Dr. Eriat’s contribution to the field goes beyond clinical care. He serves as an Adjunct Faculty in Internal Medicine and Hematology at Yenepoya University, Mangalore, where he mentors postgraduate students and young clinicians in hematology and transplant medicine.
• His commitment to academic excellence is evident from his multiple peer-reviewed publications in national and international journals on topics including stem cell mobilization failure, cytopenia management, and transplant immunology.